Cargando…

Synchronous effects of targeted mitochondrial complex I inhibitors on tumor and immune cells abrogate melanoma progression

Metabolic heterogeneity within the tumor microenvironment promotes cancer cell growth and immune suppression. We determined the impact of mitochondria-targeted complex I inhibitors (Mito-CI) in melanoma. Mito-CI decreased mitochondria complex I oxygen consumption, Akt-FOXO signaling, blocked cell cy...

Descripción completa

Detalles Bibliográficos
Autores principales:	AbuEid, Mahmoud, McAllister, Donna M., McOlash, Laura, Harwig, Megan Cleland, Cheng, Gang, Drouillard, Donovan, Boyle, Kathleen A., Hardy, Micael, Zielonka, Jacek, Johnson, Bryon D., Hill, R. Blake, Kalyanaraman, Balaraman, Dwinell, Michael B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220235/ https://www.ncbi.nlm.nih.gov/pubmed/34189432 http://dx.doi.org/10.1016/j.isci.2021.102653

Ejemplares similares

Mitochondria-targeted magnolol inhibits OXPHOS, proliferation, and tumor growth via modulation of energetics and autophagy in melanoma cells
por: Cheng, Gang, et al.
Publicado: (2020)

STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer
por: Vonderhaar, Emily P., et al.
Publicado: (2021)

Mitochondria-targeted vitamin E analogs inhibit breast cancer cell energy metabolism and promote cell death
por: Cheng, Gang, et al.
Publicado: (2013)

Combining PEGylated mito-atovaquone with MCT and Krebs cycle redox inhibitors as a potential strategy to abrogate tumor cell proliferation
por: Cheng, Gang, et al.
Publicado: (2022)

Synergistic inhibition of tumor cell proliferation by metformin and mito-metformin in the presence of iron chelators
por: Cheng, Gang, et al.
Publicado: (2019)

Corrigendum to 'A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds' [REDOX 14C (2017) 316–327]
por: Kalyanaraman, Balaraman, et al.
Publicado: (2018)

A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds
por: Kalyanaraman, Balaraman, et al.
Publicado: (2017)

Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation
por: Cheng, G, et al.
Publicado: (2014)

Changes in immune checkpoint protein expression on CD8 T cells during neoadjuvant therapy in patients with pancreatic cancer
por: Tsai, Susan, et al.
Publicado: (2014)

Teaching the basics of reactive oxygen species and their relevance to cancer biology: Mitochondrial reactive oxygen species detection, redox signaling, and targeted therapies
por: Kalyanaraman, Balaraman, et al.
Publicado: (2017)

Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models
por: Tsai, Susan, et al.
Publicado: (2018)

Therapeutic Targeting of Tumor Cells and Tumor Immune Microenvironment Vulnerabilities
por: Kalyanaraman, Balaraman, et al.
Publicado: (2022)

Antiproliferative effects of mitochondria-targeted N-acetylcysteine and analogs in cancer cells
por: Cheng, Gang, et al.
Publicado: (2023)

Fluorinated triphenylphosphonium analogs improve cell selectivity and in vivo detection of mito-metformin
por: AbuEid, Mahmoud, et al.
Publicado: (2022)

Green fluorescent proteins induce oxidative stress in cells: A worrisome new wrinkle in the application of the GFP reporter system to biological systems?
por: Kalyanaraman, Balaraman, et al.
Publicado: (2017)

Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myeloma
por: Jing, Weiqing, et al.
Publicado: (2015)

Polyphenolic Boronates Inhibit Tumor Cell Proliferation: Potential Mitigators of Oxidants in the Tumor Microenvironment
por: Cheng, Gang, et al.
Publicado: (2023)

Adoptive cell therapy using PD-1(+) myeloma-reactive T cells eliminates established myeloma in mice
por: Jing, Weiqing, et al.
Publicado: (2017)

Extending Three-Dimensional Weighted Cone Beam Filtered Backprojection (CB-FBP) Algorithm for Image Reconstruction in Volumetric CT at Low Helical Pitches
por: Tang, Xiangyang, et al.
Publicado: (2006)

2543 High concentrations of CXCL12 decrease pancreatic adenocarcinoma growth
por: Vonderhaar, Emily, et al.
Publicado: (2018)

Prevention of Tumor Growth and Dissemination by In Situ Vaccination with Mitochondria‐Targeted Atovaquone
por: Huang, Mofei, et al.
Publicado: (2022)

STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models
por: Jing, Weiqing, et al.
Publicado: (2019)

Synthesis of fluorinated triphenylphosphonium analogs that improve cancer cell selectivity and in vivo detection
por: Keyes, Robert F., et al.
Publicado: (2023)

Potent inhibition of tumour cell proliferation and immunoregulatory function by mitochondria-targeted atovaquone
por: Cheng, Gang, et al.
Publicado: (2020)

Mitochondria-targeted hydroxyurea inhibits OXPHOS and induces antiproliferative and immunomodulatory effects
por: Cheng, Gang, et al.
Publicado: (2021)

Chemoprevention of Lung Cancer with a Combination of Mitochondria-Targeted Compounds
por: Zhang, Qi, et al.
Publicado: (2022)

Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis
por: Cheng, Gang, et al.
Publicado: (2019)

Oxidation of ethidium-based probes by biological radicals: mechanism, kinetics and implications for the detection of superoxide
por: Michalski, Radosław, et al.
Publicado: (2020)

Teaching the basics of redox biology to medical and graduate students: Oxidants, antioxidants and disease mechanisms()
por: Kalyanaraman, Balaraman
Publicado: (2013)

Teaching the basics of cancer metabolism: Developing antitumor strategies by exploiting the differences between normal and cancer cell metabolism
por: Kalyanaraman, Balaraman
Publicado: (2017)

Teaching the basics of repurposing mitochondria-targeted drugs: From Parkinson's disease to cancer and back to Parkinson's disease
por: Kalyanaraman, Balaraman
Publicado: (2020)

Do free radical NETwork and oxidative stress disparities in African Americans enhance their vulnerability to SARS-CoV-2 infection and COVID-19 severity?
por: Kalyanaraman, Balaraman
Publicado: (2020)

Teaching the basics of the mechanism of doxorubicin-induced cardiotoxicity: Have we been barking up the wrong tree?
por: Kalyanaraman, Balaraman
Publicado: (2019)

Reactive oxygen species, proinflammatory and immunosuppressive mediators induced in COVID-19: overlapping biology with cancer
por: Kalyanaraman, Balaraman
Publicado: (2021)

Exploiting the tumor immune microenvironment and immunometabolism using mitochondria‐targeted drugs: Challenges and opportunities in racial disparity and cancer outcome research
por: Kalyanaraman, Balaraman
Publicado: (2022)

NAC, NAC, Knockin’ on Heaven's door: Interpreting the mechanism of action of N-acetylcysteine in tumor and immune cells
por: Kalyanaraman, Balaraman
Publicado: (2022)

Mitochondria-targeted paraquat and metformin mediate ROS production to induce multiple pathways of retrograde signaling: A dose-dependent phenomenon
por: Chowdhury, Anindya Roy, et al.
Publicado: (2020)

Mitochondria-Targeted Honokiol Confers a Striking Inhibitory Effect on Lung Cancer via Inhibiting Complex I Activity
por: Pan, Jing, et al.
Publicado: (2018)

The Chemistry of HNO: Mechanisms and Reaction Kinetics
por: Michalski, Radosław, et al.
Publicado: (2022)

Boronate-Based Probes for Biological Oxidants: A Novel Class of Molecular Tools for Redox Biology
por: Sikora, Adam, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e4on8qi14nj70ojgope8860h2b